View : 536 Download: 47

Preoperative flap-site injection with ropivacaine and epinephrine in BABA robotic and endoscopic thyroidectomy safely reduces postoperative pain A CONSORT-compliant double-blinded randomized controlled study (PAIN-BREKOR trial)

Title
Preoperative flap-site injection with ropivacaine and epinephrine in BABA robotic and endoscopic thyroidectomy safely reduces postoperative pain A CONSORT-compliant double-blinded randomized controlled study (PAIN-BREKOR trial)
Authors
Lee, Joon-HyopSuh, Yong JoonSong, Ra-YeongYi, Jin WookYu, Hyeong WonKwon, HyungjuChoi, June YoungLee, Kyu Eun
Ewha Authors
권형주
SCOPUS Author ID
권형주scopus
Issue Date
2017
Journal Title
MEDICINE
ISSN
0025-7974JCR Link

1536-5964JCR Link
Citation
MEDICINE vol. 96, no. 22
Keywords
bilateral axillo-breast approachpainthyroidectomy
Publisher
LIPPINCOTT WILLIAMS &

WILKINS
Indexed
SCIE; SCOPUS WOS
Document Type
Article
Abstract
Background: Clinical trials on bilateral axillo-breast approach (BABA) thyroidectomy show that levobupivacaine and ropivacaine significantly reduce postoperative pain, but they focused on BABA robotic thyroidectomy only and did not identify specific sites of significant pain relief. Our objective was to assess the pain reduction at various sites and safety of ropivacaine-epinephrine flap injection in BABA thyroidectomy. Methods: This prospective double-blinded randomized controlled trial was conducted in compliance with the revised CONSORT statement (ClinicalTrials.gov registration no. NCT02112370). Patients were randomized into the ropivacaine-epinephrine arm or control (normal saline) arm. Results: From January 2014 to May 2016, 148 patients participated. The primary endpoint was site-specific pain, as measured by numeric rating scale 12hours after surgery. The ropivacaine-epinephrine group exhibited significantly less swallowing difficulty (P=.008), anterior neck pain (P=.016), and right (P=.019) and left (P=.035) chest pain. Secondary endpoints were systolic (P=.402), diastolic (P=.827) blood pressure, and pulse rate (P=.397) after injection before incision and during surgery. The vital signs of the groups just after injection did not differ. During surgery, the ropivacaine-epinephrine patients had higher pulse rates (99 +/- 13.3 vs 88 +/- 16.1, P<.001) but within normal range. There were no adverse events such as postoperative nausea and vomiting. There was no significant difference in pain scores in either patient group between patients who underwent robotic or endoscopic interventions. Conclusion: BABA flap-site injection with ropivacaine and epinephrine mix before incision effectively and safely reduced postoperative pain. Future studies should focus on tailoring ropivacaine and epinephrine dosage for individuals.
DOI
10.1097/MD.0000000000006896
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
Preoperative_flap_site_injection_with_ropivacaine.17.pdf(406.15 kB) Download
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE